-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
February 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0.pdf
March 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
March 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - Rates of
self-directed perioperative cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
January 01, 2010 - Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA)
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
Draft review available for public comment from Marc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-appendices.pdf
January 16, 2023 - Rates of
self-directed perioperative Cannabidiol use
in patients undergoing total hip or knee
arthroplasty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
November 27, 2012 - harms of
prostatic biopsy are comparable
to radical prostatectomy, which is
associated with a 0.5%
perioperative
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Clinical practice guidelines for the perioperative
nutritional, metabolic, and nonsurgical support
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bivariate-methods-utility_research.pdf
November 01, 2012 - A meta-analysis comparing the prognostic accuracy
of six diagnostic tests for predicting perioperative